| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/02/2012 | EP1032403B1 Nutritional supplement for cerebral metabolic insufficiencies |
| 05/02/2012 | CN102438621A A novel formulation of metaxalone |
| 05/02/2012 | CN102438603A Prevention and treatment of sarcopenia |
| 05/02/2012 | CN102432662A Crystal form of pipecuronium bromide, preparation method and application of crystal form |
| 05/02/2012 | CN102430117A Modified proteases that inhibit complement activation |
| 05/02/2012 | CN102430060A Cold and hot temperature difference method for processing tall gastrodia tuber |
| 05/02/2012 | CN102429911A Application of ZSTK474 to preparation of medicine for treating autoimmune diseases |
| 05/01/2012 | US8168230 Platelet gel comprising platelet-rich plasma, platelet activator and polymer |
| 05/01/2012 | US8168189 Protein A compositions and methods of use |
| 05/01/2012 | CA2660577C Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone |
| 05/01/2012 | CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 04/26/2012 | WO2012054535A2 Compounds, compositions and methods useful for cholesterol mobilisation |
| 04/26/2012 | WO2012054530A2 Chemosensory receptor ligand-based therapies |
| 04/26/2012 | WO2012054528A2 Chemosensory receptor ligand-based therapies |
| 04/26/2012 | WO2012054527A2 Chemosensory receptor ligand-based therapies |
| 04/26/2012 | WO2012053994A2 Ecdysteroid analogues having plant growth promoting activity |
| 04/26/2012 | WO2012053012A2 Topical pharmaceutical compositions comprising tfflocolchicoside |
| 04/26/2012 | WO2012002773A3 Phenylcarbamate compound and muscle relaxant containing the same |
| 04/26/2012 | US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 04/26/2012 | US20120101085 Compounds And Methods For Modulating Activity Of Calcium Release Channels |
| 04/26/2012 | US20120101042 Agents and Methods for Tissue Repair and Regeneration |
| 04/26/2012 | US20120101028 Anti-inflammatory compounds and uses thereof |
| 04/26/2012 | US20120101026 Compounds For Enzyme Inhibition |
| 04/26/2012 | US20120101025 Compounds For Enzyme Inhibition |
| 04/26/2012 | US20120100120 Performance enhancing composition and method of delivering nutrients |
| 04/25/2012 | EP2444097A1 Nfat signal inhibitor and calcineurin inhibitor |
| 04/25/2012 | EP2444092A1 Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 04/25/2012 | EP2443155A1 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularih 1 (mtm1) polypeptides |
| 04/25/2012 | EP2442870A1 Pyrazinooxazepine derivatives |
| 04/25/2012 | EP1381432B9 HSA-free formulations of interferon-beta |
| 04/25/2012 | CN1278733B Viscous compositions containing carbon dioxide |
| 04/25/2012 | CN102428080A 神经营养因子活性参与的疾病的治疗或预防剂 Neurotrophic agent for treating or preventing diseases associated with the activity of Factor |
| 04/25/2012 | CN102427817A 起因于gne蛋白质功能降低的疾病的治疗用药物、食品组合物、食品添加剂 Due to the decrease in protein function gne treatment of diseases with drugs, food compositions, food additives |
| 04/25/2012 | CN102424818A Caspase-1-ES cell line induced by mifepristone |
| 04/24/2012 | US8163277 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; stent implants |
| 04/24/2012 | CA2517544C Clostridial neurotoxins for treating uterine disorders |
| 04/24/2012 | CA2486537C 4-(substituted cycloalkylmethyl)imidazole-2-thiones, 4-(substituted cycloalkenylmethyl)imidazole-2-thiones, 4-(substituted cycloalkylmethyl)imidazol-2-ones and 4-(substituted cycloalkenylmethyl)imidazol-2-ones and related compounds |
| 04/24/2012 | CA2433582C Peptides having inhibiting activity on the production of nitric oxide |
| 04/24/2012 | CA2408752C Delivery systems for treatment of vascular disease |
| 04/19/2012 | US20120095087 Enhanced products by sustainable processes for medicinal use |
| 04/19/2012 | US20120095070 Prevention and treatment of sarcopenia |
| 04/19/2012 | US20120095063 Methods and compositions for treatment of ischemic conditions and conditions related to mitochondrial function |
| 04/19/2012 | US20120095049 Nociceptin analogs |
| 04/19/2012 | US20120095041 Reversible nondepolarizing neuromuscular blockade agents and methods for their use |
| 04/19/2012 | US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS |
| 04/19/2012 | US20120094971 Compositions Including 6-Aminohexanoic Acid Derivatives As HDAC Inhibitors |
| 04/19/2012 | US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE |
| 04/19/2012 | US20120094942 Chemosensory Receptor Ligand-Based Therapies |
| 04/19/2012 | US20120093946 Use of carbon dioxide supplying means for muscle strengthening and method of increasing cattle meat thereby |
| 04/19/2012 | US20120093928 Oral metaxalone compositions |
| 04/19/2012 | US20120093887 Amorphous varenicline tartrate co-precipitates |
| 04/19/2012 | US20120093866 Formulation for stabilizing proteins, which is free of mammalian excipient |
| 04/19/2012 | CA2814500A1 Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
| 04/18/2012 | EP1499358B1 Ph-sensitive polymer |
| 04/18/2012 | CN102421450A 治疗虚弱的方法 Method of treating weak |
| 04/18/2012 | CN102417480A Spirocyclic nitriles as protease inhibitors |
| 04/18/2012 | CN101601740B 一种治疗重症肌无力的药物及其制备方法 A myasthenia gravis and preparation method of treatment |
| 04/17/2012 | US8158617 Fused heterocyclic compound and use thereof |
| 04/17/2012 | CA2513717C Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 04/17/2012 | CA2493843C Azolidinone-vinyl fused-benzene derivatives |
| 04/17/2012 | CA2347928C Cell surface molecule-induced macrophage activation |
| 04/12/2012 | US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene |
| 04/12/2012 | US20120088783 Chroman derivatives |
| 04/12/2012 | US20120088751 Pharmaceutical compounds |
| 04/12/2012 | US20120088744 Compositions for treating cmt and related disorders |
| 04/12/2012 | US20120088732 Therapeutic composition comprising a botulinum neurotoxin |
| 04/12/2012 | US20120087925 Method for the treatment of inflammatory disorders |
| 04/12/2012 | US20120087912 Treatment methods using dkk-1 antibodies |
| 04/12/2012 | US20120087858 Dual variable domain immunoglobulins and uses thereof |
| 04/11/2012 | EP2439204A1 Heterocyclic compound and hematopoietic stem cell amplifier |
| 04/11/2012 | EP2438921A1 23-O-Acetylshengmanol-3-O-beta-D-xylopyranoside and its medical use |
| 04/11/2012 | EP2119718B1 Macrocyclic compound |
| 04/11/2012 | EP1957082B1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 04/11/2012 | EP1334120B1 Modified clostridial neurotoxins with altered biological persistence |
| 04/11/2012 | CN102408470A Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 04/11/2012 | CN102406837A 治疗痿证的中药制剂 Chinese medicine treatment of flaccidity |
| 04/11/2012 | CN102406798A 用于治疗重症肌无力的中药组合物 Chinese medicine composition for the treatment of myasthenia gravis |
| 04/11/2012 | CN101277976B 抗肌抑制素抗体 Anti-myostatin antibodies |
| 04/10/2012 | CA2632567C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 04/10/2012 | CA2473754C Treatment of ms with goat serum |
| 04/10/2012 | CA2445253C Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/10/2012 | CA2438921C Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 04/10/2012 | CA2330660C Muscle-derived cell mediated gene delivery for treating muscle-and bone-related injury or dysfunction |
| 04/05/2012 | WO2012043808A1 Heat shock protein expression inducer |
| 04/05/2012 | WO2012043393A1 Emulsion composition |
| 04/05/2012 | US20120083502 Heterocyclic compounds and their uses |
| 04/05/2012 | US20120083495 Compounds for the treatment of spinal muscular atrophy and other uses |
| 04/05/2012 | US20120083494 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors |
| 04/05/2012 | US20120083469 Inhibitors of arginase and their therapeutic applications |
| 04/05/2012 | US20120083464 Neuroprotective properties of 5'-methylthioadenosine |
| 04/05/2012 | US20120083442 Myostatin binding agents |
| 04/04/2012 | EP2435407A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
| 04/04/2012 | EP2435403A2 Thiocolchicine derivatives, method of making and methods of use thereof |
| 04/04/2012 | EP2435067A2 Stem cell targeting |
| 04/04/2012 | EP1799709B1 Myostatin isoform |
| 04/04/2012 | EP1434798B1 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 04/04/2012 | CN102397479A 一种治疗破伤风的中药制剂 A method of treating tetanus Chinese medicine |
| 04/04/2012 | CN102397272A Application of butylphthalide and derivatives thereof in preparation of medicines for preventing and treating ALS |
| 04/04/2012 | CN102397261A 盐酸奈福泮药物组合物及其制备方法 Nefopam pharmaceutical composition and its preparation method |
| 04/03/2012 | CA2434930C Treating pulmonary disorders with gaseous agent causing repletion of gsno |